Experimental evidence suggests that adherence is a prerequisite for ba
cterial infection. We demonstrated that transitional cells at the surf
ace of the bladder are coated with glycosaminoglycans (proteoglycans a
nd mucus) whose presence efficiently decreases bacterial adherence to
the mucosa. Exposure of mucus to protamine sulfate, a quaternary amine
(known to form salts with glycosaminoglycans, and inactivate them) si
gnificantly increases the bacterial adherence to the bladder. Investig
ators have primarily focused on bacterial surface factors (that is pil
l or fimbriae, glycocalix) in relation to the ability to adhere. We ex
plored the hypothesis that Escherichia coli produces a soluble virulen
ce factor that increases the infection rate in rabbits by promoting ba
cterial adherence to the bladder mucosa. In addition, it was proposed
that this factor is a quaternary amine similar to protamine. For these
studies an in vivo bacterial infection assay (which we described prev
iously in rabbits) was used to examine E. coli metabolic products (sol
uble virulence factor) that could promote bacterial persistence in the
bladder by perturbing mucus (glycosaminoglycans), and promote bacteri
al adherence and virulence. E. coli was grown in human urine and a bac
terial-free supernatant was collected. Rabbit bladders were then expos
ed to either this supernatant or to the same human urine that was not
infected with E. coli. Results show a significantly higher bacterial p
ersistence (bacterial count) in bladders pretreated with urine contain
ing the E. coli supernatants compared to controls pretreated with unin
fected urine (p = 0.03). The molecular weight of the putative soluble
virulence factor is less than 3.5 kD. (p = 0.056) based on dialysis st
udies and binds to heparin agarose affinity chromatography matrix, sug
gesting that it is cationic and capable of adhering to the highly anio
nic bladder mucus (glycosaminoglycans).